Streamlining Cigna Entyvio Prior Authorization Workflows
Klivira provides integrated solutions to optimize the Cigna Entyvio prior authorization process, connecting directly with Cigna Healthcare and Evernorth channels to accelerate approvals for this high-volume specialty medication.
For revenue cycle directors and prior authorization coordinators, managing specialty drug PAs can be a significant operational burden. Entyvio (vedolizumab), a critical treatment for inflammatory bowel diseases, frequently requires stringent prior authorization from payers like Cigna Healthcare, often involving both medical and pharmacy benefit reviews. Klivira's platform is engineered to mitigate these complexities, offering a structured approach to automate and accelerate submissions.
Understanding Cigna Entyvio Prior Authorization Pathways
Entyvio (vedolizumab) is a targeted biologic therapy for moderately to severely active ulcerative colitis and Crohn's disease. Due to its high cost and specific indications, Cigna Healthcare mandates prior authorization for both medical and pharmacy benefit coverage. The submission pathway depends on whether Entyvio is administered in-office (medical benefit) or dispensed by a specialty pharmacy for self-administration (pharmacy benefit).
Key Submission Channels for Entyvio PA with Cigna
- Medical Benefit Submissions: For Entyvio administered under the medical benefit, prior authorization requests are primarily submitted via CignaforHCP.com, Cigna Healthcare's provider portal. X12 278 transactions are also supported through clearinghouses.
- Pharmacy Benefit Submissions: When Entyvio is covered under the pharmacy benefit, prior authorizations are managed by Evernorth's Express Scripts, the PBM serving Cigna.
- Electronic Prior Authorization (ePA): Express Scripts leverages established ePA platforms, including CoverMyMeds and Surescripts, for prescriber-initiated pharmacy benefit workflows.
- Specialty Pharmacy Coordination: Accredo, Evernorth's specialty pharmacy, handles specialty injectable and complex medication PAs on the pharmacy benefit, aligning with Express Scripts' processes.
Cigna Healthcare's Policy and Medical Necessity Criteria for Entyvio
Cigna Healthcare publishes comprehensive coverage policies and medical-necessity guidelines on its public provider site. These policies outline clinical indications, step therapy requirements, and documentation standards for drugs like Entyvio. Klivira's platform can help integrate these policy requirements into your workflow, ensuring submissions align with Cigna-developed or externally sourced criteria.
Streamlining Entyvio PA with Klivira's Integration Capabilities
Klivira integrates directly with your EMR system and connects to Cigna Healthcare's provider portal (CignaforHCP.com) and Evernorth's Express Scripts pharmacy systems. This dual-channel connectivity automates data extraction, form population, and submission tracking, reducing manual effort and potential for errors in the Entyvio prior authorization process.
Common Denial Patterns and Appeal Pathways for Entyvio with Cigna
Denials for Entyvio prior authorizations from Cigna Healthcare often stem from insufficient documentation, failure to meet step therapy requirements, or site-of-service mismatches. Klivira's platform helps identify potential denial risks pre-submission and supports efficient appeal management. Cigna provides clear appeal pathways on its provider portal, including peer-to-peer review options for clinical denials, with distinct processes for commercial and Medicare Advantage plans.
Turnaround Times and Regulatory Compliance
Cigna Healthcare adheres to state-mandated turnaround times for commercial prior authorizations. For Medicare Advantage plans, Cigna is subject to the phased compliance timeline of CMS-0057-F, requiring standard PAs within 72 hours and expedited PAs within 24 hours. Klivira's automation helps your team meet these critical deadlines by accelerating submission and status monitoring.
Frequently asked questions
What is Entyvio used for, and why does Cigna require prior authorization?
Entyvio (vedolizumab) treats moderately to severely active ulcerative colitis and Crohn's disease. Cigna Healthcare requires prior authorization due to the drug's specialty status, high cost, and specific clinical criteria, ensuring it is medically necessary and appropriately prescribed according to their coverage policies.
How does Klivira help with Cigna Entyvio prior authorizations for both medical and pharmacy benefits?
Klivira's platform connects to CignaforHCP.com for medical benefit submissions and integrates with Evernorth's Express Scripts for pharmacy benefit PAs. This dual connectivity allows for automated data exchange, form submission, and status tracking across both channels, streamlining the entire Entyvio prior authorization workflow.
What are common reasons for a Cigna Entyvio prior authorization denial?
Common denial reasons include incomplete clinical documentation, failure to meet Cigna Healthcare's step therapy requirements, or non-adherence to site-of-service guidelines. Klivira helps identify and address these issues proactively, improving the likelihood of initial approval.
Can Klivira assist with appeals for denied Cigna Entyvio prior authorizations?
Yes, Klivira supports the appeal process by centralizing documentation and facilitating communication. While Klivira does not provide legal advice, it helps organize the necessary information for submitting appeals through Cigna Healthcare's documented pathways, including preparing for peer-to-peer reviews.
Does Cigna use ePA for Entyvio?
Yes, for pharmacy benefit Entyvio, Evernorth's Express Scripts utilizes established electronic prior authorization (ePA) platforms like CoverMyMeds and Surescripts. Klivira's system can integrate with these ePA channels to facilitate efficient electronic submissions.
Related coverage
Other entyvio prior authorization by payer
- Navigating Aetna Entyvio Prior Authorization for IBD Management
- Optimizing Anthem (Elevance Health) Entyvio Prior Authorization Workflows
- Navigating Humana Entyvio Prior Authorization
- Streamlining Medicaid Entyvio Prior Authorization Workflows
- Streamlining Medicare Entyvio Prior Authorization Workflows
- Navigating UnitedHealthcare Entyvio Prior Authorization
Other entyvio prior authorization by specialty
- Streamlining Entyvio Prior Authorization for Cardiology Practices
- Streamlining Entyvio Prior Authorization for Endocrinology Practices
- Streamlining Entyvio Prior Authorization for Gastroenterology
- Streamlining Entyvio Prior Authorization for Oncology Patients
- Optimizing Entyvio Prior Authorization for Orthopedics
Ready to automate prior auth for this drug?
See how Klivira automates prior authorizations for your team.
Request a demo